-
Add to Cart The item has been addedA335095-250mgAurora kinase inhibitor III is a potent ATP-competitive aurora related kinase (also designated ARK) inhibitor. Aurora kinase inhibitor III is a cell-permeable, 2,4-dianilinopyrimidine compound which has been used to study a variety of tumor types. -
Add to Cart The item has been addedA335095-25mgAurora kinase inhibitor III is a potent ATP-competitive aurora related kinase (also designated ARK) inhibitor. Aurora kinase inhibitor III is a cell-permeable, 2,4-dianilinopyrimidine compound which has been used to study a variety of tumor types. -
Add to Cart The item has been addedA335095-50mgAurora kinase inhibitor III is a potent ATP-competitive aurora related kinase (also designated ARK) inhibitor. Aurora kinase inhibitor III is a cell-permeable, 2,4-dianilinopyrimidine compound which has been used to study a variety of tumor types. -
Add to Cart The item has been addedA335095-5mgAurora kinase inhibitor III is a potent ATP-competitive aurora related kinase (also designated ARK) inhibitor. Aurora kinase inhibitor III is a cell-permeable, 2,4-dianilinopyrimidine compound which has been used to study a variety of tumor types. -
-
-
-
-
Add to Cart The item has been addedA412409-10mgInformationAvacopan (CCX168) Avacopan (CCX168) is an orally administered and selective C5a receptor (C5aR) antagonist.TargetsC5aR. -
Add to Cart The item has been addedA412409-25mgInformationAvacopan (CCX168) Avacopan (CCX168) is an orally administered and selective C5a receptor (C5aR) antagonist.TargetsC5aR. -
Add to Cart The item has been addedA412409-50mgInformationAvacopan (CCX168) Avacopan (CCX168) is an orally administered and selective C5a receptor (C5aR) antagonist.TargetsC5aR. -
Add to Cart The item has been addedA412409-5mgInformationAvacopan (CCX168) Avacopan (CCX168) is an orally administered and selective C5a receptor (C5aR) antagonist.TargetsC5aR.
